Repligen (RGEN) Tops Q1 EPS by 20c; Lowers FY Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $175.32 -1.65%
Financial Fact:
(Loss) income from operations: 3.75M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
(Loss) income from operations: 3.75M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q1 EPS of $0.92, $0.20 better than the analyst estimate of $0.72. Revenue for the quarter came in at $206.4 million versus the consensus estimate of $185.48 million.
GUIDANCE:
Repligen sees FY2022 EPS of $3.07-$3.15, versus the consensus of $3.25. Repligen sees FY2022 revenue of $770-800 million, versus the consensus of $819.5 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Southwest Gas (SWX) Tops Q3 EPS by 2c; Offers Guidance
- Reservoir Media, Inc. (RSVR) Tops Q2 EPS by 2c; offers guidance
- CS Disco, Inc (LAW) Misses Q3 EPS by 6c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
